Keymed Biosciences Inc. (HKG:2162)
48.00
-0.10 (-0.21%)
Apr 3, 2025, 4:08 PM HKT
Keymed Biosciences Revenue
In the year 2024, Keymed Biosciences had annual revenue of 428.12M CNY with 20.91% growth. Keymed Biosciences had revenue of 373.44M in the half year ending December 31, 2024, with 592,665.08% growth.
Revenue
428.12M CNY
Revenue Growth
+20.91%
P/S Ratio
27.60
Revenue / Employee
340.32K CNY
Employees
1,258
Market Cap
13.23B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 29.60B |
Hansoh Pharmaceutical Group Company | 13.05B |
WuXi Biologics | 19.87B |
JD Health International | 61.89B |
Innovent Biologics | 10.03B |
Akeso | 2.26B |
Alibaba Health Information Technology | 31.39B |
Sino Biopharmaceutical | 30.72B |